Michele Gottshall

FDA investigator

Appears on 12 documents from 2020 to 2026, mostly at sites in Pennsylvania. Most often cites production record review (21 CFR 211.192).

12
Documents on file
3.8
Observations per 483
2020
First seen
2026
Most recent

What they cite most

From 47 observations

Activity by year

2020: 1, 2021: 1, 2022: 3, 2023: 5, 2025: 1, 2026: 1

Where

Pennsylvania 6 · Canada 3 · Japan 2

Is Michele Gottshall coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

12 documents, newest first
FirmOpen
483 B Positive National Blood Services -Feb 2, 2026 · Wyoming, Pennsylvania
483 DB Biologics, LLCJun 18, 2025
483 HAMARI PFST, Ltd.Nov 10, 2023 · Hachimampara, Japan
483 Astellas Pharma Inc.Oct 27, 2023 · Yaizu, Japan
483 BWXT Medical Ltd.Mar 3, 2023 · Ottawa, Canada
483 Patheon Inc.Feb 24, 2023 · Mississauga, Canada
483 Patheon Inc.Feb 17, 2023 · Whitby, Canada

About this profile

What does Michele Gottshall inspect?

Michele Gottshall appears on 12 documents on file covering 12 sites, mostly in Pennsylvania.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.67 and 21 CFR 211.22.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Michele Gottshall is dated Feb 2, 2026.

FDA Investigator Michele Gottshall: 483s & Inspections · FDA Intel